Cerulean Pharma reported $0 in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Agile Therapeutics AGRX:US $ 16.43M 0.4M
Arrowhead Research ARWR:US $ 0M 0M
Bayer BAYN:GR € 41766M 1394M
Biocept BIOC:US $ 2.96M 0.15M
Brainstorm Cell Therapeutics BCLI:US $ 0M 0M
Cerulean Pharma CERU:US $ 0M 0M
Macrogenics MGNX:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Perrigo Ordinary Shares PRGO:US $ 3550.3M 5.6M
Seattle Genetics SGEN:US $ 0M 0M
YTE INCY:US $ 33.78M 0.47M